MX2019013192A - Método de tratamiento y diseño de ensayo clínico para la atrofia geográfica debida a la degeneración macular relacionada con la edad. - Google Patents
Método de tratamiento y diseño de ensayo clínico para la atrofia geográfica debida a la degeneración macular relacionada con la edad.Info
- Publication number
- MX2019013192A MX2019013192A MX2019013192A MX2019013192A MX2019013192A MX 2019013192 A MX2019013192 A MX 2019013192A MX 2019013192 A MX2019013192 A MX 2019013192A MX 2019013192 A MX2019013192 A MX 2019013192A MX 2019013192 A MX2019013192 A MX 2019013192A
- Authority
- MX
- Mexico
- Prior art keywords
- brimonidine
- age
- geographic atrophy
- macular degeneration
- clinical trial
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/498—Pyrazines or piperazines ortho- and peri-condensed with carbocyclic ring systems, e.g. quinoxaline, phenazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F9/00—Methods or devices for treatment of the eyes; Devices for putting-in contact lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
- A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
- A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
- A61K9/0051—Ocular inserts, ocular implants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Pathology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
Abstract
Métodos para tratar o ralentizar el crecimiento de una lesión asociada con la atrofia geográfica y métodos para evaluar un fármaco o agente para su uso en tratar, reducir el avance de o ralentizar el crecimiento de una lesión asociada con la atrofia geográfica.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762502375P | 2017-05-05 | 2017-05-05 | |
PCT/US2018/031048 WO2018204759A1 (en) | 2017-05-05 | 2018-05-04 | Brimonidine for use and clinical trial design for geographic atrophy due to age-related macular degeneration |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2019013192A true MX2019013192A (es) | 2020-01-13 |
Family
ID=62555156
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2019013192A MX2019013192A (es) | 2017-05-05 | 2018-05-04 | Método de tratamiento y diseño de ensayo clínico para la atrofia geográfica debida a la degeneración macular relacionada con la edad. |
Country Status (14)
Country | Link |
---|---|
US (2) | US20180318302A1 (es) |
EP (1) | EP3618832A1 (es) |
JP (1) | JP2020518626A (es) |
KR (1) | KR20190142399A (es) |
CN (1) | CN110769829A (es) |
AU (1) | AU2018261171A1 (es) |
BR (1) | BR112019023223A2 (es) |
CA (1) | CA3062455A1 (es) |
CL (1) | CL2019003172A1 (es) |
MX (1) | MX2019013192A (es) |
PH (1) | PH12019502483A1 (es) |
RU (1) | RU2019136781A (es) |
WO (1) | WO2018204759A1 (es) |
ZA (1) | ZA201907329B (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113035298B (zh) * | 2021-04-02 | 2023-06-20 | 南京信息工程大学 | 递归生成大阶数行限制覆盖阵列的药物临床试验设计方法 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8969415B2 (en) * | 2006-12-01 | 2015-03-03 | Allergan, Inc. | Intraocular drug delivery systems |
JP6511401B2 (ja) * | 2013-02-15 | 2019-05-15 | アラーガン、インコーポレイテッドAllergan,Incorporated | 持続型薬物送達インプラント |
-
2018
- 2018-05-04 CA CA3062455A patent/CA3062455A1/en not_active Abandoned
- 2018-05-04 AU AU2018261171A patent/AU2018261171A1/en not_active Abandoned
- 2018-05-04 EP EP18729818.7A patent/EP3618832A1/en not_active Withdrawn
- 2018-05-04 WO PCT/US2018/031048 patent/WO2018204759A1/en active Application Filing
- 2018-05-04 MX MX2019013192A patent/MX2019013192A/es unknown
- 2018-05-04 CN CN201880040757.XA patent/CN110769829A/zh active Pending
- 2018-05-04 BR BR112019023223-0A patent/BR112019023223A2/pt not_active Application Discontinuation
- 2018-05-04 KR KR1020197035615A patent/KR20190142399A/ko unknown
- 2018-05-04 JP JP2019560293A patent/JP2020518626A/ja active Pending
- 2018-05-04 US US15/971,555 patent/US20180318302A1/en not_active Abandoned
- 2018-05-04 RU RU2019136781A patent/RU2019136781A/ru not_active Application Discontinuation
-
2019
- 2019-11-04 PH PH12019502483A patent/PH12019502483A1/en unknown
- 2019-11-05 CL CL2019003172A patent/CL2019003172A1/es unknown
- 2019-11-05 ZA ZA2019/07329A patent/ZA201907329B/en unknown
-
2020
- 2020-11-24 US US17/103,613 patent/US20210213017A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA3062455A1 (en) | 2018-11-08 |
AU2018261171A1 (en) | 2019-12-05 |
CL2019003172A1 (es) | 2020-04-13 |
RU2019136781A (ru) | 2021-06-07 |
US20210213017A1 (en) | 2021-07-15 |
CN110769829A (zh) | 2020-02-07 |
KR20190142399A (ko) | 2019-12-26 |
PH12019502483A1 (en) | 2020-07-20 |
JP2020518626A (ja) | 2020-06-25 |
EP3618832A1 (en) | 2020-03-11 |
WO2018204759A1 (en) | 2018-11-08 |
BR112019023223A2 (pt) | 2020-05-26 |
US20180318302A1 (en) | 2018-11-08 |
ZA201907329B (en) | 2021-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG10201908697XA (en) | A pharmaceutical composition for use in the treatment or prevention of a c5-related disease and a method for treating or preventing a c5-related disease | |
MX2019001517A (es) | Complejos de nanopartículas de albúmina modificada con anticuerpos para el tratamiento del cáncer. | |
MX2017012380A (es) | Derivados de maitansinoide, conjugados de los mismos, y metodos de uso. | |
HK1257839A1 (zh) | 金字塔形狀的乳房植入物用於增大,重建,或提升和其使用和製造方法 | |
MX2018014868A (es) | Composiciones y metodos de uso de nintedanib para mejorar el exito de la cirugia del glaucoma. | |
MX2021007268A (es) | Formas solidas de acido {[5-(3-clorofenil)-3-hidroxipiridin-2-carb onil]amino}acetico, composiciones, y usos de las mismas. | |
WO2019040106A3 (en) | COMPOUNDS, RELATED SALTS AND METHODS FOR THE TREATMENT OF DISEASES | |
CL2015002835A1 (es) | Nuevos derivados de piridina | |
MX2016009251A (es) | Derivados de 7-oxo-1, 6-diazabiciclo [3.2.1] octano y su uso como agentes antibacterianos. | |
EA033446B1 (ru) | Гетероциклическое соединение для лечения дегенерации желтого пятна и/или болезни штаргардта | |
PH12016501349A1 (en) | Hydroxy formamide derivatives and their use | |
MX2020001875A (es) | Forma polimorfica de tg02. | |
AU2015267099A8 (en) | Use of eribulin in the treatment of cancer | |
PH12016502243A1 (en) | Pharmaceutical compositions for treating infectious diseases | |
PH12018502161A1 (en) | Methods of treatment for cholestatic and fibrotic diseases | |
WO2015066302A3 (en) | Compositions, methods of use, and methods of treatment | |
NZ721835A (en) | An osseointegrable device | |
EP3648779A4 (en) | USE OF VAGINAL LACTOBACILLES TO IMPROVE IN VITRO FERTILIZATION SUCCESS RATE | |
MX2020000636A (es) | Proteinas sinteticas y usos terapeuticos de las mismas. | |
PH12019502483A1 (en) | Brimonidine for use and clinical trial design for geographic atrophy due to age-related macular degeneration | |
PH12019502380A1 (en) | Compositions and methods for treating retinopathy | |
MX2017000118A (es) | Biocontrol de enfermedades asociadas a la semilla en plantulas. | |
WO2018211324A8 (en) | Prodrugs for the treatment of disease | |
UA87159U (ru) | Способ предпосевной обработки семян пшеницы | |
WO2018211323A8 (en) | Heterocyclic compounds for the treatment of disease |